首页> 外文期刊>The British Journal of Nutrition >Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats
【24h】

Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats

机译:姜黄素衰减大鼠胆管结扎诱导的肝纤维化和胰岛素抵抗

获取原文
获取原文并翻译 | 示例
       

摘要

Recent studies have strongly indicated the hepatoprotective effect of curcumin; however, the precise mechanisms are not well understood. This study aimed to determine the protective effect of curcumin on hepatic damage and hepatic insulin resistance in biliary duct ligated (BDL) fibrotic rat model. To accomplish this, male Wistar rats were divided into four groups (eight for each): sham group, BDL group, sham+Cur group and BDL+Cur group. The last two groups received curcumin at a dose of 100 mg/kg daily for 4 weeks. The mRNA/protein expression levels of Ras-related C3 botulinum toxin substrate 1 (Rac1), Rac1-GTP, dinucleotide phosphate oxidase 1 (NOX1), signal transducer and activator of transcription 3 (STAT3), suppressor of cytokine signalling 3 (SOCS3), insulin receptor substrate 1 (IRS1), extracellular signal-regulated kinase 1 (ERK1), specific protein 1 (Sp1) and hypoxia-inducible factor-1α (HIF-1α) were measured by real-time PCR and Western blotting, respectively. Fasting blood glucose, insulin and Leptin levels were determined and homoeostasis model assessment-estimated insulin resistance, as an index of insulin resistance, was calculated. Curcumin significantly attenuated liver injury and fibrosis, including amelioration of liver histological changes, reduction of hepatic enzymes, as well as decreased expression of liver fibrogenesis-associated variables, including Rac1, Rac1-GTP, NOX1, ERK1, HIF-1α and Sp1. Curcumin also attenuated leptin level and insulin resistance, which had increased in BDL rats (P0·05). Furthermore, compared with the BDL group, we observed an increase in IRS1 and a decrease in SOCS3 and STAT3 expression in the curcumin-treated BDL group (P0·05), indicating return of these parameters towards normalcy. In conclusion, Curcumin showed hepatoprotective activity against BDL-induced liver injury and hepatic insulin resistance by influencing the expression of some genes/proteins involved in these processes, and the results suggest that it can be used as a therapeutic option.
机译:最近的研究表明姜黄素的肝脏保护作用;然而,确切的机制并不顺利。本研究旨在确定姜黄素对胆管粘性(BDL)纤维化大鼠模型中肝损伤和肝胰岛素抗性的保护作用。为了实现这一点,将雄性Wistar大鼠分为四组(每次八个):假组,BDL组,假+ Cur组和BDL + Cur组。最后两组在每天100mg / kg的剂量下接受姜黄素4周。 RAS相关C3肉毒杆菌毒素谱系1(RAC1),RAC1-GTP,二核苷酸磷酸氧化酶1(NOX1),信号传感器和转录3(STAT3),细胞因子信号3的抑制(SOCS3) ,通过实时PCR和Western印迹测量胰岛素受体底物1(IRS1),细胞外信号调节激酶1(ERK1),特异性蛋白质1(SP1)和缺氧诱导因子-1α(HIF-1α)。测定了空腹血糖,胰岛素和瘦蛋白水平,并计算出同种型模型评估估计的胰岛素抵抗,作为胰岛素抗性指数。姜黄素显着减弱肝损伤和纤维化,包括肝脏组织学变化的改善,肝酶的减少,以及肝纤维发生相关变量的表达,包括RAC1,RAC1-GTP,NOx1,ERK1,HIF-1α和SP1。姜黄素还减弱瘦素水平和胰岛素抗性,其在BDL大鼠(P <0·05)中增加。此外,与BDL组相比,我们观察到姜黄素处理的BD1基团(P <0·05)中的IRS1和SOCS3和STAT3表达的增加,表明这些参数朝向正常的返回。总之,姜黄素通过影响这些方法的一些基因/蛋白的表达,姜黄素对BDL诱导的肝损伤和肝胰岛素抵抗力表现出来,结果表明它可以用作治疗选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号